Table 2. Age- and Race/Ethnicity-Adjusted Trends in the Prevalence of Ideal Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016.
| Proportion With Ideal Level of Total Cholesterol, % (95% CI)a | β (95% CI), %/y | Proportion With Ideal Level of HDL Cholesterol, % (95% CI)a | β (95% CI), %/y | Proportion With Ideal Level of Non-HDL Cholesterol, % (95% CI)a | β (95% CI), %/y | ||||
|---|---|---|---|---|---|---|---|---|---|
| 1999-2000 | 2015-2016 | 2007-2008 | 2015-2016 | 2007-2008 | 2015-2016 | ||||
| All youths | 61.3 (58.0 to 64.6) |
71.4 (69.0 to 73.8) |
0.8 (0.6 to 0.9) |
68.2 (65.6 to 70.9) |
75.4 (72.1 to 78.7) |
0.7 (0.2 to 1.1) |
69.6 (66.5 to 72.7) |
77.9 (75.5 to 80.3) |
1.0 (0.5 to 1.4) |
| Age group, y | |||||||||
| 6-8 | 58.2 (52.8 to 63.5) |
70.2 (64.8 to 75.5) |
0.8 (0.4 to 1.2) |
75.4 (69.6 to 81.2) |
83.2 (79.0 to 87.4) |
1.0 (0.2 to 1.8) |
73.0 (66.5 to 79.5) |
80.0 (76.5 to 83.6) |
0.6 (−0.2 to 1.4) |
| 9-11 | 50.9 (41.6 to 60.3) |
68.7 (63.1 to 74.2) |
1.1 (0.6 to 1.5) |
69.8 (65.4 to 74.1) |
78.8 (74.8 to 82.9) |
0.9 (0.2 to 1.6) |
61.2 (55.7 to 66.7) |
78.8 (74.9 to 82.7) |
1.9 (1.1 to 2.7) |
| 12-15 | 64.8 (59.6 to 70.0) |
74.2 (69.8 to 78.6) |
0.8 (0.5 to 1.1) |
64.5 (59.8 to 69.2) |
71.9 (65.8 to 77.9) |
0.5 (−0.3 to 1.4) |
72.9 (67.1 to 78.8) |
78.2 (74.3 to 82.0) |
0.6 (−0.2 to 1.4) |
| 16-19 | 66.2 (61.4 to 71.0) |
70.4 (65.9 to 75.0) |
0.5 (0.2 to 0.7) |
63.4 (58.8 to 68.0) |
69.2 (64.3 to 74.1) |
0.4 (−0.3 to 1.2) |
68.1 (64.4 to 71.9) |
73.7 (68.6 to 78.8) |
0.9 (0.2 to 1.6) |
| Males | 64.2 (60.5 to 67.9) |
71.7 (69.0 to 74.4) |
0.7 (0.5 to 0.9) |
66.9 (62.9 to 70.9) |
73.5 (69.5 to 77.4) |
0.6 (−0.1 to 1.2) |
70.9 (67.1 to 74.7) |
76.6 (73.2 to 79.9) |
0.8 (0.2 to 1.3) |
| Age group, y | |||||||||
| 6-11 | 59.1 (53.5 to 64.7) |
68.5 (64.4 to 72.5) |
0.7 (0.4 to 1.1) |
78.2 (74.7 to 81.6) |
83.8 (80.0 to 88.1) |
0.6 (−0.02 to 1.2) |
69.9 (64.5 to 75.3) |
78.7 (75.7 to 81.6) |
0.9 (0.2 to 1.6) |
| 12-19 | 67.3 (63.4 to 71.1) |
73.9 (69.4 to 78.4) |
0.7 (0.4 to 0.9) |
56.5 (51.1 to 62.0) |
63.8 (58.5 to 69.1) |
0.6 (−0.3 to 1.5) |
71.1 (66.2 to 76.1) |
74.2 (69.4 to 78.9) |
0.6 (−0.1 to 1.3) |
| Females | 58.3 (54.3 to 62.4) |
71.2 (67.9 to 74.5) |
0.8 (0.6 to 1.1) |
69.6 (66.5 to 72.7) |
77.5 (73.9 to 81.1) |
0.8 (0.2 to 1.3) |
68.2 (63.2 to 73.2) |
79.5 (76.1 to 82.9) |
1.2 (0.5 to 1.8) |
| Age group, y | |||||||||
| 6-11 | 50.7 (43.6 to 57.8) |
70.8 (65.0 to 76.6) |
1.2 (0.7 to 1.6) |
67.3 (61.3 to 73.3) |
78.7 (75.1 to 82.2) |
1.4 (0.6 to 2.2) |
64.3 (56.9 to 71.7) |
80.7 (75.8 to 85.5) |
1.6 (0.7 to 2.6) |
| 12-19 | 63.5 (57.9 to 69.1) |
71.4 (68.2 to 74.6) |
0.6 (0.4 to 0.9) |
71.6 (68.0 to 75.2) |
77.2 (72.4 to 82.0) |
0.3 (−0.4 to 1.0) |
70.4 (64.9 to 76.0) |
78.3 (74.3 to 82.3) |
0.9 (0.1 to 1.6) |
| Proportion With Ideal Level of Triglycerides, % (95% CI)a | β (95% CI), %/y | Proportion With Ideal Level of LDL Cholesterol, % (95% CI)a | β (95% CI), %/y | Proportion With Ideal Level of Apolipoprotein B, % (95% CI)a | β (95% CI), %/y | ||||
| 1999-2000 | 2013-2014 | 1999-2000 | 2013-2014 | 2005-2006 | 2013-2014 | ||||
| All adolescents | 63.4 (59.5 to 67.2) |
76.7 (70.8 to 82.5) |
1.0 (0.6 to 1.4) |
77.9 (72.8 to 83.1) |
84.1 (79.8 to 88.4) |
0.5 (0.2 to 0.8) |
85.8 (81.3 to 90.4) |
87.9 (84.8 to 91.0) |
0.3 (−0.3 to 0.9) |
| Age group, y | |||||||||
| 12-15 | 62.3 (55.5 to 69.1) |
78.2 (70.6 to 85.8) |
1.2 (0.7 to 1.7) |
78.7 (72.9 to 84.4) |
83.0 (77.1 to 88.9) |
0.5 (0.1 to 1.0) |
87.6 (83.0 to 92.2) |
88.1 (83.5 to 92.6) |
0.01 (−0.8 to 0.8) |
| 16-19 | 65.1 (58.8 to 71.5) |
75.6 (68.1 to 83.1) |
0.8 (0.2 to 1.3) |
77.6 (71.2 to 84.0) |
85.7 (80.3 to 91.0) |
0.5 (−0.02 to 1.0) |
84.3 (78.6 to 90.0) |
88.0 (82.9 to 93.1) |
0.6 (−0.3 to 1.5) |
| Males | 64.1 (58.6 to 69.6) |
73.7 (66.3 to 81.2) |
0.8 (0.2 to 1.4) |
76.6 (69.5 to 83.7) |
87.2 (80.9 to 93.4) |
0.7 (0.2 to 1.1) |
87.1 (82.3 to 91.9) |
90.3 (85.1 to 95.5) |
0.2 (−0.5 to 1.0) |
| Females | 62.9 (57.2 to 68.7) |
79.3 (72.7 to 85.9) |
1.2 (0.7 to 1.7) |
79.3 (73.5 to 85.0) |
81.0 (75.7 to 86.2) |
0.4 (−0.1 to 0.8) |
84.5 (77.6 to 91.5) |
85.5 (80.8 to 90.2) |
0.4 (−0.6 to 1.3) |
The following ideal levels were defined by the 2011 National Heart, Lung, and Blood Institute Expert Panel Guidelines: total cholesterol, less than 170 mg/dL; high-density lipoprotein (HDL) cholesterol, greater than 45 mg/dL; non-HDL cholesterol, less than 120 mg/dL; triglycerides, less than 90 mg/dL; low-density lipoprotein (LDL) cholesterol, less than 110 mg/dL; and apolipoprotein B, less than 90 mg/dL.20 All estimates are based on population-weighted data from the National Health and Nutrition Examination Survey. The unweighted sample size ranges for each lipid and survey cycle are as follows: total cholesterol in 1999-2000, the minimum was 411 (females aged 6-11 years) and the maximum was 2930 (all youths); HDL and non-HDL cholesterol in 2007-2008, minimum of 481 (females aged 6-8 years) and maximum of 2055 (all youths); HDL, non-HDL, and total cholesterol in 2015-2016, minimum of 493 (males aged 6-11 years) and maximum of 2099 (all youths); triglycerides in 1999-2000, minimum of 429 (adolescents aged 16-19 years) and maximum of 904 (all adolescents); LDL cholesterol in 1999-2000, minimum of 424 (adolescents aged 16-19 years) and maximum of 892 (all adolescents); apolipoprotein B in 2005-2006, minimum of 413 (female adolescents) and maximum of 851 (all adolescents); triglycerides and apolipoprotein B in 2013-2014, minimum of 256 (male adolescents) and maximum of 532 (all adolescents); and LDL cholesterol in 2013-2014, minimum of 255 (male adolescents) and maximum of 531 (all adolescents).